FindTrial
Sign In

Comparison of efficacy of Core decompression along with intraosseous ibandronate versus core decompression alone in osteonecrosis of femoral head

FUNCTIONAL AND RADIOLOGICAL OUTCOMES OF CORE DECOMPRESSION ALONG WITH INTRAOSSEOUS IBANDRONATE COMPARED TO CORE DECOMPRESSION ALONE IN NON TRAUMATIC PRE COLLAPSE OSTEONECROSIS OF FEMORAL HEAD

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/06/042976
Enrollment
30
Registered
2022-06-02
Start date
Unknown
Completion date
Unknown
Last updated
2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical Health Condition 2: M879- Osteonecrosis, unspecified

Interventions

Intervention1: Core decompression along with intraosseous ibandronate: Core decompression along with intraosseous ibandronate(bisphosphonate) used in patients of avascular necrosis of femoral head in

Sponsors

Nil
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Osteonecrosis of femoral head [stage 1,2a,2b(crescent sign)]; modified FICAT and ARLET staging 2. No history of hip trauma

Exclusion criteria

Exclusion criteria: 1. Traumatic AVN/osteonecrosis 2. AVN/osteonecrosis in advanced post-collapse stages 3. Patients with chronic kidney disease stage 4. Patient not willing to give consent for the study

Design outcomes

Primary

MeasureTime frame
Disease progression/ improvement Measurement of Kerboul angle Functional outcome: VAS, patient satisfactionTimepoint: 4 weeks, 8 weeks, 3 months, and 6 months—

Secondary

MeasureTime frame
Complications if any like infection, fractures, etc.Timepoint: 4 weeks, 8 weeks, 3 months, and 6 months—

Countries

India

Contacts

Public ContactDr Monu Mahan

PGIMER,Chandigarh

drprasoonksingh@gmail.com9781002142

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026